Bilirubinometer
Dräger | JM-105 - Transcutaneous Bilirubinometer
The Dräger JM-105 Transcutaneous Bilirubinometer maintains the quality of screenings throughout the device's entire lifespan, offering a cost-effective advantage: it optimizes the efficiency of jaundice treatment programs, saving time and money, while ensuring an exceptional standard of care.
Effective Jaundice Screening
With the Dräger JM-105 transcutaneous bilirubinometer, it is possible to accurately identify at-risk infants from 24 weeks of gestation. Effective screening can reduce the number of neonates readmitted to the hospital and shorten the length of stay. The ability to obtain reliable results in just seconds, rather than hours, enhances patient safety and accelerates decision-making. The newly integrated patient identification feature allows for the monitoring of infants who require special care and adherence to hospital jaundice management protocols.
Improved Efficiency of Procedures and Costs
The Dräger JM-105 transcutaneous bilirubinometer simplifies jaundice screening practices, reducing the number of time-consuming blood draws and easing the laboratory workload, resulting in cost savings. It enhances efficiency by providing reliable results with fewer steps, allowing more time for direct patient care. The data transfer functionality and barcode scanner optimize the screening program and minimize the risk of human error. Since the JM-105 probe tip is reusable, there is no need for disposable materials. Given the volume of screenings performed in neonatal units, over time, the cost of disposables can exceed the initial cost of the device. Therefore, this instrument saves both time and money while maintaining an exceptional standard of care.
The Dräger JM-105 transcutaneous bilirubinometer is gentle for the infant and efficient for the operator
Easy to Use, for Everyone
The Dräger JM-105 transcutaneous bilirubinometer expands the concept of ease of use by simplifying the experience for everyone involved. When performing a TcB measurement with the JM-105 compared to an invasive TSB measurement, both fragile neonates and their parents experience less stress, and the operator's task becomes easier. Screening with the JM-105 is fast and simple: just clean the reusable tip with an alcohol-soaked cloth and perform the measurement. No time wasted with disposable tips. Additionally, as the device is connected to the hospital’s information system, jaundice screening data is transferred directly to the infant's electronic medical record accurately and effortlessly. In short, the Dräger JM-105 transcutaneous bilirubinometer is gentle for the infant and efficient for the operator.
The offer includes:
- MU20105 - JM-105 Bilirubinometer
- OPC4181 - JM-105 Barcode Scanner
- OPC4182 - AC Adapter
This product is reserved for industry professionals and comes with a 12-month warranty. Replenishment times are approximate; due to raw material shortages and logistical issues, supply may exceed the indicated restocking time.
